The principal investigator is expected to attend the Scientific Advisory Committee meeting to present the research proposal. This provides an opportunity to clarify issues and facilitate the review process. If the principal investigator is unable to attend the meeting, another member of the investigative team may present the protocol as long as that individual is familiar with the study and is qualified to address issues of a scientific nature. The protocol managers are able to assign specific presentation times so the presence of the investigative team isn't required for the complete duration of the meeting. Protocols that have already received scientific review from another source (ex. Cancer Center, NIH) do not need to be presented.
The presenter will give a brief descriptive summary of the protocol, detailing how the CRS resources will be used. The Chair will then lead an open discussion, starting with the assigned scientific reviewers and biostatistician, followed by questions or concerns from the committee. After this discussion, the investigator will be asked to leave the meeting to allow the committee to complete its review in closed discussion. Investigators will be informed of the committee's decision (either approval, approval pending response to questions/concerns, or deferral) following the meeting.
Early application submission is encouraged to allow for scientific / biostatistical reviews as well as space use and resource evaluation by the Core Managers. Applications can be submitted simultaneously with the IRB, however a final CRS approval will not be granted until IRB approval has been confirmed.
For meeting dates and times per location, please contact [email protected].
